SOCRA CCRP Site Management 1 — Questions and Answers
Question 1: What is the purpose of a site initiation visit (SIV) in clinical research?
- To screen the first study subject
- To train site staff on the protocol, procedures, and regulatory requirements before study initiation (Correct answer)
- To conduct the first monitoring visit after enrollment begins
- To audit the site's financial records
Correct answer: To train site staff on the protocol, procedures, and regulatory requirements before study initiation
The SIV is conducted by the sponsor/CRO before enrollment to ensure site staff are trained on the protocol, CRF completion, safety reporting, and study-specific procedures.
Question 2: What is a 'delegation log' (also called a 'delegation of authority log') at a clinical trial site?
- A record of sponsor payments to the site
- A document identifying each staff member's qualifications and the specific trial tasks they are authorized to perform (Correct answer)
- A log of protocol deviations delegated to subinvestigators
- A record of IRB meeting attendance
Correct answer: A document identifying each staff member's qualifications and the specific trial tasks they are authorized to perform
A delegation log records each study team member's qualifications (CV, training) and the specific tasks they are authorized to perform, signed by the PI.
Question 3: What is the role of a Clinical Research Coordinator (CRC)?
- To serve as the Principal Investigator for the trial
- To coordinate day-to-day trial activities, support subject visits, maintain regulatory documents, and ensure protocol compliance (Correct answer)
- To independently monitor the trial on behalf of the sponsor
- To conduct medical assessments and determine subject eligibility
Correct answer: To coordinate day-to-day trial activities, support subject visits, maintain regulatory documents, and ensure protocol compliance
The CRC manages the operational aspects of clinical trials including subject coordination, regulatory document maintenance, data collection, and communication with sponsor and IRB.
Question 4: What must be verified during a site feasibility assessment?
- Only the investigator's publishing record
- Site's patient population, staff qualifications, facilities, regulatory experience, and competing studies (Correct answer)
- Whether the site has previously enrolled in any trial
- Only the IRB turnaround time at that institution
Correct answer: Site's patient population, staff qualifications, facilities, regulatory experience, and competing studies
Site feasibility assesses the available patient population, investigator and staff qualifications and experience, facilities, equipment, and competing workload.
Question 5: What is the purpose of a 'close-out visit' at the end of a clinical trial?
- To enroll the final subject in the study
- To reconcile trial supplies, ensure records are complete, archive documents, and confirm all outstanding issues are resolved (Correct answer)
- To present study results to site staff
- To conduct the final data monitoring before database lock
Correct answer: To reconcile trial supplies, ensure records are complete, archive documents, and confirm all outstanding issues are resolved
The close-out visit ensures all unused drug is reconciled and returned, all essential documents are archived, outstanding data queries are resolved, and the site is properly closed.
Question 6: What is meant by 'subject recruitment and retention' strategies in clinical trial site management?
- Strategies to hire and retain site staff
- Planned approaches to identify, enroll, and keep subjects participating throughout the trial (Correct answer)
- Methods to retain study drug supplies at the site
- Protocols for retaining regulatory documents post-trial
Correct answer: Planned approaches to identify, enroll, and keep subjects participating throughout the trial
Recruitment strategies identify eligible subjects and motivate enrollment, while retention strategies reduce dropout through follow-up reminders, visit flexibility, and participant engagement.
What is the purpose of a site initiation visit (SIV) in clinical research?